Sensei Biotherapeutics, Inc Overview
Company Headquarters: Massachusetts, US
Founded: 1999
Workforce: ~56
Company Working: Sensei Biotherapeutics is the fastest-growing biopharmaceutical company, which is engaged in the discovery, and development of next-generation immunotherapies with an initial focus on treatments for cancer. The company is majorly involved in the development of novel product candidates that integrate next-generation technologies. The company developed a strong set of R&D capabilities and infrastructure to provide support for the discovery and advancement of antibody product candidates. The company has a strong distribution network in North America, Europe, Asia-Pacific, and the Rest of the World.
Strategy
Sensei Biotherapeutics is focused on the development of antibodies for the treatment of tumors. The company utilizes a combination of committed commercial resources, regional commercial resources, and distributorships to market, sell, and distribute its products across the globe. It also focuses on winning in established markets, accelerating development in emerging markets, innovating for value, simplifying, and improving the operating model, and supplementing organic growth.
